Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DLW69V
|
|||
| Drug Name |
1,2,3,4,5,6-hexabromocyclohexane
|
|||
| Synonyms |
1,2,3,4,5,6-Hexabromocyclohexane; 1837-91-8; Benzene hexabromide; Cyclohexane, 1,2,3,4,5,6-hexabromo-; Hexabromocyclohexane; JAK2 Inhibitor II; ACMC-1BQJT; SCHEMBL459442; trans-alpha-Benzene hexabromide; CHEMBL444236; DTXSID4052687; CHEBI:93940; NSC7908; HMS3268H22; HMS3413C10; HMS3677C10; NSC-7908; ZINC1586309; ANW-23174; MFCD00059127; s5902; Cyclohexane,2,3,4,5,6-hexabromo-; AKOS015836040; 1,2,3,4,5,6-Hexabromo-cyclohexane; 1,2,3,4,5,6-Hexabromocyclohexane #; NCGC00092358-01; NCGC00092358-02; 1,2,3,4,5,6-hexakis(bromanyl)cyclohexane; A4510; FT-0633875; JAK2 Inhibitor II - CAS 1837-91-8; 1,2,3,4,5,6-Hexabromocyclohexane;NSC7908; A812818; 1,2,3,4,5,6-Hexabrom-cyclohexan (I(2)-Form); J-011778; 1,2,3,4,5,6-Hexabromocyclohexane, >=98% (HPLC); BRD-K06817181-001-01-5; Q27165694
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H6Br6
|
|||
| Canonical SMILES |
C1(C(C(C(C(C1Br)Br)Br)Br)Br)Br
|
|||
| InChI |
1S/C6H6Br6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H
|
|||
| InChIKey |
QFQZKISCBJKVHI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1837-91-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:93940
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr. 2007 Nov;137(11):2366-70. | |||
| REF 2 | Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. J Med Chem. 2005 Apr 7;48(7):2526-33. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.